Central Nervous System Neoplasms
"Central Nervous System Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
Descriptor ID |
D016543
|
MeSH Number(s) |
C04.588.614.250 C10.551.240
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Neoplasms".
This graph shows the total number of publications written about "Central Nervous System Neoplasms" by people in UAMS Profiles by year, and whether "Central Nervous System Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 3 | 0 | 3 | 2023 | 3 | 0 | 3 | 2022 | 1 | 0 | 1 | 2021 | 2 | 0 | 2 | 2020 | 1 | 0 | 1 | 2019 | 1 | 0 | 1 | 2017 | 1 | 0 | 1 | 2016 | 1 | 3 | 4 | 2015 | 1 | 0 | 1 | 2014 | 2 | 0 | 2 | 2013 | 3 | 0 | 3 | 2009 | 1 | 0 | 1 | 2008 | 1 | 0 | 1 | 2007 | 1 | 0 | 1 | 2006 | 0 | 1 | 1 | 2005 | 1 | 2 | 3 | 2004 | 3 | 0 | 3 | 2002 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Central Nervous System Neoplasms" by people in Profiles over the past ten years.
-
Morris M, Ararat K, Cutshall H, Gokden M, Rodriguez A, Rooper L, Lindberg M, Nix JS. SMARCA4-deficient central nervous system metastases: A case series and systematic review. J Neuropathol Exp Neurol. 2024 Aug 01; 83(8):638-654.
-
Bielamowicz KJ, Littrell MB, Albert GW, Parker LS, Jayappa S, Aldape K, Gokden M. Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse. J Neurooncol. 2024 Jun; 168(2):367-373.
-
Rogers JL, Wall T, Acquaye-Mallory AA, Boris L, Kim Y, Aldape K, Quezado MM, Butman JA, Smirniotopoulos JG, Chaudhry H, Tsien CI, Chittiboina P, Zaghloul K, Aboud O, Avgeropoulos NG, Burton EC, Cachia DM, Dixit KS, Drappatz J, Dunbar EM, Forsyth P, Komlodi-Pasztor E, Mandel J, Ozer BH, Lee EQ, Ranjan S, Lukas RV, Raygada M, Salacz ME, Smith-Cohn MA, Snyder J, Soldatos A, Theeler BJ, Widemann BC, Camphausen KA, Heiss JD, Armstrong TS, Gilbert MR, Penas-Prado M. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors. J Neurooncol. 2024 Apr; 167(2):349-359.
-
Langston RG, Pinckard-Dover H, Guzman G, Wardell CP, Gokden M, Morris TW, Day JD, Rodriguez A. Intracranial hematolymphoid malignancies: A case series with molecular characterization. Clin Neurol Neurosurg. 2023 10; 233:107928.
-
Yu N, Lee HS, Raslan OA, Jin LW, Aboud O. H3G34-mutant diffuse hemispheric glioma with osseous metastases: a case report and literature review. CNS Oncol. 2023 06 01; 12(2):CNS95.
-
Siddiqui MZ, Elhusseiny AM, Phillips PH, Ramakrishnaiah RH, Gokden M, Carrillo LF, Chacko JG. Diffuse Leptomeningeal Glioneuronal Tumor Presenting With Progressive Cranial Neuropathies. J Neuroophthalmol. 2024 Mar 01; 44(1):e129-e131.
-
Smith HL, Wadhwani N, Horbinski C. Major Features of the 2021 WHO Classification of CNS Tumors. Neurotherapeutics. 2022 10; 19(6):1691-1704.
-
Nieblas-Bedolla E, Christophers B, Williams JR, Power-Hays A, Jimenez N, Rodriguez A. Racial and ethnic disparities among children with primary central nervous system tumors in the US. J Neurooncol. 2021 May; 152(3):451-466.
-
Mascarenhas L, Ogawa C, Laetsch TW, Weigel BJ, Bishop MW, Krystal J, Borinstein SC, Slotkin EK, Muscal JA, Hingorani P, Levy DE, Mo G, Shahir A, Wright J, DuBois SG. Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors. Cancer Med. 2021 02; 10(3):843-856.
-
Zhang Y, Zhou DB. Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment. Chin Med J (Engl). 2020 Jun 20; 133(12):1462-1469.
-
Morales H, Marko N, Brannock K, Kanfi A, Chaudhary R. Primary CNS Lymphoma Presenting as Enhancing Cortical Ribboning and Hemorrhage : Lessons from Atypical Presentation of a?Usual Suspect. Clin Neuroradiol. 2020 Sep; 30(3):625-628.
-
Badros A, Singh Z, Dhakal B, Kwok Y, MacLaren A, Richardson P, Trikha M, Hari P. Marizomib for central nervous system-multiple myeloma. Br J Haematol. 2017 04; 177(2):221-225.
-
Kleindienst SJ, Dhar S, Nielsen DW, Griffith JW, Lundy LB, Driscoll C, Neff B, Beatty C, Barrs D, Zapala DA. Identifying and Prioritizing Diseases Important for Detection in Adult Hearing Health Care. Am J Audiol. 2016 Sep 01; 25(3):224-31.
-
Cao S, Wendl MC, Wyczalkowski MA, Wylie K, Ye K, Jayasinghe R, Xie M, Wu S, Niu B, Grubb R, Johnson KJ, Gay H, Chen K, Rader JS, Dipersio JF, Chen F, Ding L. Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep. 2016 06 24; 6:28294.
-
Coffey N, Torres C, Glikstein R, Al Mansoori T, Del Carpio-O'Donovan R, Patro S. Imaging Findings in Sensorineural Hearing Loss: A Pictorial Essay. Can Assoc Radiol J. 2017 May; 68(2):106-115.
-
Jurczyszyn A, Grzasko N, Gozzetti A, Czepiel J, Cerase A, Hungria V, Crusoe E, Silva Dias AL, Vij R, Fiala MA, Caers J, Rasche L, Nooka AK, Lonial S, Vesole DH, Philip S, Gangatharan S, Druzd-Sitek A, Walewski J, Corso A, Cocito F, Vekemans MC, Atilla E, Beksac M, Leleu X, Davila J, Badros A, Aneja E, Abildgaard N, Kastritis E, Fantl D, Schutz N, Pika T, Butrym A, Olszewska-Szopa M, Usnarska-Zubkiewicz L, Usmani SZ, Nahi H, Chim CS, Shustik C, Madry K, Lentzsch S, Swiderska A, Helbig G, Guzicka-Kazimierczak R, Lendvai N, Waage A, Andersen KT, Murakami H, Zweegman S, Castillo JJ. Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice. Am J Hematol. 2016 06; 91(6):575-80.
-
Shiramizu B, Goldman S, Smith L, Agsalda-Garcia M, Galardy P, Perkins SL, Frazer JK, Sanger W, Anderson JR, Gross TG, Weinstein H, Harrison L, Barth MJ, Mussolin L, Cairo MS. Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report. Br J Haematol. 2015 Aug; 170(3):367-71.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|